PATENT CLAIM ANALYSIS

Application Number: 15971017
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "183000"]

Abstract:
This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Claim (Index 17):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein Cy A3  is optionally substituted with R A  selected from CH 3 , CN, OH, CH 2 CH 2 OH, CH 2 CH 2 OCH 3 , C(O)CH 3 , C(O)CH 2 CH 3 , C(O)CH(CH 3 ) 2 , C(O)CH 2 OH, C(O)CH(CH 3 )OH, S(O) 2 CH 3 , C(O)OCH 3 , C(O)N(CH 3 ) 2 , C(O)NH(CH 3 ), C(O)N(CH 2 CH 3 ) 2 , C(O)NH(CH 2 CH 3 ), C(O)N(CH 3 )(CH 2 CH 3 ), CH 2 C(O)N(CH 3 ) 2 , N(CH 3 ) 2 , and C(O)(morpholin-4-yl).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.13793
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15469975', '15234690', '15624850', '15247499', '15151259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8459786144163994
- 35 USC 102 Novelty (BERT): 0.6145918160115557
- Combined Prediction Score: 0.8228399345759151
- Mean Citation Score: 531.0717219999998
- Max Citation Score: 638.51373
- Similarity Product: 493.81537321677087

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test